IBI306

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for IBI306, covering 2021-07-01 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI306 in Participants With Hypercholesterolemia [Phase 3]